Weight-loss and diabetes drugs reduced the risk of developing Alzheimer’s, an independent study published Monday showed.The ...

Merck & Co has ended a second phase 3 trial ... Pharma has not given up the hunt for new drugs for Alzheimer’s – despite the setbacks a report by ResearchersAgainstAlzheimer’s last year ...

Merck CEO Rob Davis told CNBC's Jim Cramer that ... He also pointed to Winrevair, a medicine used to treat a rare and life-threatening lung condition that was approved by the Food and Drug ...